ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
复制标题
通过使用单克隆大鼠抗人淋巴细胞抗体 (CAMPATH-1) 体外消除同种异体反应性淋巴细胞来消除移植物抗宿主病
DOI:
10.1016/s0140-6736(84)92564-9
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
Shimon Slavin
中科院分区:
文献类型:
--
作者:
H. Waldmann;Geoff Hale;G. Cividalli;Z. Weshler;D. Manor;E. Rachmilewitz;A. Polliak;Reuven Or;Lola Weiss;S. Samuel;C. Brautbar;Shimon Slavin
A new monoclonal rat anti-human lymphocyte antibody (CAMPATH-1) which lyses cells with autologous human complement was used for depletion of T lymphocytes from human bonemarrow allografts in vitro before transplantation in 11 high-risk patients. HLA-matched siblings were used as marrow donors. T-cell depletion was substantial when measured by E-rosette formation (0-0·18% residual T cells) and immunofluorescence with a monoclonal anti-T-cell antibody (0-0·5%). No anti-graft-versus-host disease prophylaxis was given after transplantation. Rapid engraftment was reported in all patients, and the post-transplantation course was uneventful. No signs of graft-versus-host disease developed in any of the patients, who were observed for a maximum period of 12 months. The method might be suitable for larger-scale studies in high-risk patients. The late graft failure seen in 2 patients may reflect residual host resistance uncompromised by GvHD.
登录
查看更多内容
影响因子:
6.2
作者:
Vallera,DA;Soderling,CC;Carlson,GJ;Kersey,JH
通讯作者:
Kersey,JH
影响因子:
158.5
作者:
RAMSAY, NKC;KERSEY, JH;NESBIT, ME
通讯作者:
NESBIT, ME
影响因子:
20.3
作者:
Reisner,Y;Kapoor,N;Kirkpatrick,D;Pollack,MS;Cunningham-Rundles,S;Dupont,B;Hodes,MZ;Good,RA;O'Reilly,RJ
通讯作者:
O'Reilly,RJ
DOI:
10.1016/0090-1229(82)90128-3
发表时间:
1982
期刊:
Clinical immunology and immunopathology
影响因子:
--
作者:
Vallera,DA;Filipovich,A;Soderling,CC;Kersey,JH
通讯作者:
Kersey,JH